Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural configuration enables selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in the production of investigational oncology drugs where stereochemical precision is critical for biological activity. Also utilized in research settings for designing peptidomimetic compounds with improved metabolic stability and bioavailability.